Latest News | Emcure Pharmaceuticals To Launch Anti-Covid Pill In Week
[email protected]10 Jan, 2022News
New Delhi, Dec 31 (PTI) Emcure Pharmaceuticals Ltd (EPL) on Friday said it will launch its generic version of anti-COVID-19 pill Molnupiravir in a week in India. The company plans to launch Molnupiravir under the brand name 'Lizuvira' in the Indian market, EPL said in a statement. "As the need for such a drug is imminent in the face of emerging challenges in COVID-19 treatment, EPL will endeavour to deliver Lizuvira (Molnupiravir) in a week's time. A toll-free helpline will be dedicated to help the doctors and patients access the product," it added.
Related Bookmarks
- Emcure Pharmaceuticals To Launch Oral COVID-19 Drug In A Week�s Time In India
- 11 Best Cat Toys That Indoor and Outdoor Pets Will Love to Play With for Hours
- Emcure Pharma To Launch Oral Covid Drug For Emergency Use In India
- Advantages Of Using Sliding Gates Mosman In Businesses
- Performance Testing Learning Which Leads To Growth In Learner�s Career
- Comprehensive Cleaning Solution From Carpet Cleaning Sydney
- Online Classes For LKG in India
- Best Smart LED TV in India | LED TV manufacturers in India
- Wholesale DID
- How Student Tutoring North Shore Helps Students To Prepare For OC Tests
Recent Profiles
All Call Plumbing Llc
Shefahospital
Hitclub
Vin88 M7uscom
Daniel Oei
Go8
Megan Aquino
Bigbassbonanza
Columbus Cleaning Services
William Tan